Samsung Life says no decision yet on reported US insurer stake investment review

• Samsung Life reissued an “undetermined” clarification on a media report it was pursuing large insurance acquisitions in the UK and US.
• It is reviewing various domestic and overseas investments to secure new growth engines, including a potential equity investment in a US insurer.
• No specific decision has been made.
• An update is expected when details are decided or by Dec. 31, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Samsung Life Insurance Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261002800172), on October 02, 2026, and is solely responsible for the information contained therein.